BioMarin Pharmaceutical Inc
BMRN· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $300.13M | $250.14M | $191.79M | $136.81M |
| Net Income | -$419.01M | -$81.99M | -$33.50M | -$21.53M |
| EPS Diluted | -$2.58 |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.51 |
| -$0.23 |
| -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.